TET1 has been shown to overcome chemotherapy resistance in pancreatic ductal adenocarcinoma by reducing the activity of the cell adhesion molecule L1 like (CHL1)-associated Hedgehog signaling pathway. Here, TET1 is linked to pancreatic ductal adenocarcinoma.